Hypothalamic Function Before and After Bariatric Surgery
Hypothalamic Morphology, Neuronal Activity and Systems Biology in Response to Food Intake in Obese Patients With Type 2 Diabetes Mellitus Compared to Obese and Lean Controls
1 other identifier
observational
48
1 country
1
Brief Summary
The purpose of this study is to determine the effect of gastric banding or gastric bypass on hypothalamic morphology and function, gut hormones and systems biology in obese subjects with and without type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 21, 2010
CompletedFirst Posted
Study publicly available on registry
July 22, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedDecember 24, 2012
December 1, 2012
1.7 years
July 21, 2010
December 20, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in gut hormones
3 weeks
Study Arms (1)
obesity diabetes, surgical and dietary
Interventions
Standard RYGB and LAGB procedures
3 months of using the prodimed diet
Eligibility Criteria
Obese (type 2 diabetic or not) population from primary care (dietary intervention) and hospital setting (bariatric surgery)
You may qualify if:
- Patients aged 35-65 years;
- BMI \> 40 kg/m2;
- BMI \> 35 and \<40 kg/m2 with co-morbidity, which is expected to improve after surgically-induced weight loss;
- A history of longstanding obesity (\>5 years);
- Proven failed attempts to lose weight in a conventional way, or primarily successful weight loss with eventual weight regain;
- Intention to adhere to a postoperative follow-up programme.
You may not qualify if:
- BMI\> 50 or body weight \> 150 kg (because it is impossible to safely put people above this weight on a standard table for MRI);
- Subjects with disease related obesity, i.e. Cushing or medication related obesity;
- Use of medication known to affect glucose or lipid metabolism (i.e. prednisone)
- Monogenetic diabetes: MODY, Mitochondrial diabetes;
- LADA (adult-onset latent autoimmune diabetes); detected by c-peptide measurement on screening.
- Impaired renal function (serum creatinine \> 176 μmol/L);
- Leg ulcers, gangrene.
- Any genetic or psychiatric disease (e.g. fragile X syndrome, major depression) affecting the brain
- Any significant chronic disease
- Renal or hepatic disease
- Pregnancy
- Recent weight changes or attempts to loose weight (\> 3 kg weight gain or loss, within the last 3 months)
- Aerobic exercise more that 3 times 60 minutes a week
- Alcohol consumption of more than 28 units per week at present or in the past
- Recent blood donation (within the last 2 months)
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Leiden University Medical Centre
Leiden, South Holland, 2333 ZA, Netherlands
Related Publications (4)
Maessen DE, Hanssen NM, Lips MA, Scheijen JL, Willems van Dijk K, Pijl H, Stehouwer CD, Schalkwijk CG. Energy restriction and Roux-en-Y gastric bypass reduce postprandial alpha-dicarbonyl stress in obese women with type 2 diabetes. Diabetologia. 2016 Sep;59(9):2013-7. doi: 10.1007/s00125-016-4009-1. Epub 2016 Jun 16.
PMID: 27312699DERIVEDLips MA, Van Klinken JB, van Harmelen V, Dharuri HK, 't Hoen PA, Laros JF, van Ommen GJ, Janssen IM, Van Ramshorst B, Van Wagensveld BA, Swank DJ, Van Dielen F, Dane A, Harms A, Vreeken R, Hankemeier T, Smit JW, Pijl H, Willems van Dijk K. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes. Diabetes Care. 2014 Dec;37(12):3150-6. doi: 10.2337/dc14-0195. Epub 2014 Oct 14.
PMID: 25315204DERIVEDLips MA, Wijngaarden MA, van der Grond J, van Buchem MA, de Groot GH, Rombouts SA, Pijl H, Veer IM. Resting-state functional connectivity of brain regions involved in cognitive control, motivation, and reward is enhanced in obese females. Am J Clin Nutr. 2014 Aug;100(2):524-31. doi: 10.3945/ajcn.113.080671. Epub 2014 Jun 25.
PMID: 24965310DERIVEDLips MA, Pijl H, van Klinken JB, de Groot GH, Janssen IM, Van Ramshorst B, Van Wagensveld BA, Swank DJ, Van Dielen F, Smit JW. Roux-en-Y gastric bypass and calorie restriction induce comparable time-dependent effects on thyroid hormone function tests in obese female subjects. Eur J Endocrinol. 2013 Aug 28;169(3):339-47. doi: 10.1530/EJE-13-0339. Print 2013 Sep.
PMID: 23811187DERIVED
Biospecimen
Blood/Sera Adipose tissue biopsies
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hanno Pijl, MD Phd Proff
Leiden University Medical Centre
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- drs
Study Record Dates
First Submitted
July 21, 2010
First Posted
July 22, 2010
Study Start
June 1, 2009
Primary Completion
February 1, 2011
Study Completion
May 1, 2012
Last Updated
December 24, 2012
Record last verified: 2012-12